APGE — APOGEE THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  9 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in APOGEE THERAPEUTICS INC (APGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.29% (2024 Q1)
Avg. % of fund
0.84%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 290,000 — 0% 0.56% $11.5M $39.73
2025 Q2 UNCHANGED 290,000 — 0% 0.89% $12.6M $43.43
2025 Q1 UNCHANGED 290,000 — 0% 0.80% $10.8M $37.36
2024 Q4 UNCHANGED 290,000 — 0% 0.96% $13.1M $45.30
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APGE price (monthly, adj. close)

Other funds also holding APGE

As of 2025 Q4 — sorted by position size

VR Adviser, LLC 3Y 31.67% Remedium Capital Partners, LLC 25.88% Fairmount Funds Management LLC 3Y 11.77% GREAT POINT PARTNERS LLC 3Y 7Y 9.15% Affinity Asset Advisors, LLC 3Y 5.31% First Turn Management, LLC 4.1% Opaleye Management Inc. 3Y 7Y 3.87% Novo Holdings A/S 3Y 7Y 3.34% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.14% Paradigm Biocapital Advisors LP 3Y 2.16%
← Back to Commodore Capital LP Holdings